Stock Scorecard
Stock Summary for Royalty Pharma plc - Class A (RPRX) - $26.22 as of 11/20/2024 8:39:30 PM EST
Total Score
14 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for RPRX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RPRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RPRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RPRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RPRX (67 out of 90)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 10 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 9 |
Latest News for for RPRX
Financial Details for RPRX
Company Overview |
|
|---|---|
| Ticker | RPRX |
| Company Name | Royalty Pharma plc - Class A |
| Country | USA |
| Description | Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/13/2025 |
Stock Price History |
|
| Last Day Price | 26.22 |
| Price 4 Years Ago | 45.72 |
| Last Day Price Updated | 11/20/2024 8:39:30 PM EST |
| Last Day Volume | 2,003,746 |
| Average Daily Volume | 2,439,429 |
| 52-Week High | 30.92 |
| 52-Week Low | 24.80 |
| Last Price to 52 Week Low | 5.73% |
Valuation Measures |
|
| Trailing PE | 10.16 |
| Industry PE | 22.60 |
| Sector PE | 40.32 |
| 5-Year Average PE | 10.30 |
| Free Cash Flow Ratio | 11.65 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 1.54 |
| Total Cash Per Share | 2.25 |
| Book Value Per Share Most Recent Quarter | 15.40 |
| Price to Book Ratio | 1.66 |
| Industry Price to Book Ratio | 5.31 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 6.68 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 444,302,000 |
| Market Capitalization | 11,649,598,440 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/15/2024 |
| Last Dividend Amount | 0.21 |
| Current Dividend Amount | 0.21 |
| Total Years Dividend Increasing | 4 |
| Trailing Annual Dividend Rate | 0.84 |
| Trailing Annual Dividend Yield | 3.20% |
| Forward Annual Dividend Rate | 1.16 |
| Forward Annual Dividend Yield | 4.44% |
| 5-Year Dividend Payments Count | 18 |
| 3-Year Average Dividend Yield | 2.16% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 5.26% |
| 3-Year Dividend Growth Rate Percentage | 8.47% |
| 5-Year Dividend Growth Rate Percentage | 38.67% |
| All-Time Dividend Growth Rate Percentage | 38.67% |
| Dividend Payout Ratio | 33.07% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 659.00% |
| Annual Earnings Growth | 2,549.50% |
| Reported EPS 12 Trailing Months | 2.54 |
| Reported EPS Past Year | 2.95 |
| Reported EPS Prior Year | 4.38 |
| Net Income Twelve Trailing Months | 1,145,109,000 |
| Net Income Past Year | 1,134,834,000 |
| Net Income Prior Year | 42,832,000 |
| Quarterly Revenue Growth YOY | 5.30% |
| 5-Year Revenue Growth | 3.52% |
| Operating Margin Twelve Trailing Months | 1.30 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 998,552,000 |
| Total Cash Past Year | 495,310,000 |
| Total Cash Prior Year | 1,736,472,000 |
| Net Cash Position Most Recent Quarter | -6,608,827,000 |
| Net Cash Position Past Year | -5,639,975,000 |
| Long Term Debt Past Year | 6,135,285,000 |
| Long Term Debt Prior Year | 7,116,322,000 |
| Total Debt Most Recent Quarter | 7,607,379,000 |
| Equity to Debt Ratio Past Year | 0.62 |
| Equity to Debt Ratio Most Recent Quarter | 0.57 |
| Total Stockholder Equity Past Year | 10,084,289,000 |
| Total Stockholder Equity Prior Year | 9,525,373,000 |
| Total Stockholder Equity Most Recent Quarter | 10,258,467,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 131,426,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.30 |
| Free Cash Flow Past Year | 872,280,000 |
| Free Cash Flow Prior Year | 102,828,000 |
Options |
|
| Put/Call Ratio | 5.33 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.41 |
| MACD Signal | -0.27 |
| 20-Day Bollinger Lower Band | 25.44 |
| 20-Day Bollinger Middle Band | 27.45 |
| 20-Day Bollinger Upper Band | 29.47 |
| Beta | 0.47 |
| RSI | 34.02 |
| 50-Day SMA | 27.83 |
| 150-Day SMA | 32.79 |
| 200-Day SMA | 34.31 |
System |
|
| Modified | 11/19/2024 11:49:42 AM EST |